Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2794023096', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs17-gs6-07', 'title': "Abstract GS6-07: EMBRACA: A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician's choice of therapy in patients with advanced breast cancer and a germline <i>BRCA</i> mutation", 'display_name': "Abstract GS6-07: EMBRACA: A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician's choice of therapy in patients with advanced breast cancer and a germline <i>BRCA</i> mutation", 'publication_year': 2018, 'publication_date': '2018-02-15', 'ids': {'openalex': 'https://openalex.org/W2794023096', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs17-gs6-07', 'mag': '2794023096'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs17-gs6-07', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5014713051', 'display_name': 'Jennifer K. Litton', 'orcid': 'https://orcid.org/0000-0001-8390-4985'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'J Litton', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049358292', 'display_name': 'HS Rugo', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'HS Rugo', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048706345', 'display_name': 'Johannes Ettl', 'orcid': 'https://orcid.org/0000-0003-4754-8447'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'J Ettl', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5068059897', 'display_name': 'Sara A. Hurvitz', 'orcid': 'https://orcid.org/0000-0001-7808-7191'}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'S Hurvitz', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I2800389475', 'https://openalex.org/I2800124591', 'https://openalex.org/I2802835388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006642161', 'display_name': 'Anthony Gonçalvès', 'orcid': 'https://orcid.org/0000-0001-7570-7439'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'A Gonçalves', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101924464', 'display_name': 'Kyung Ho Lee', 'orcid': 'https://orcid.org/0000-0002-0108-3376'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'K-H Lee', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I2800389475', 'https://openalex.org/I4210167126']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5074479466', 'display_name': 'Louis Fehrenbacher', 'orcid': 'https://orcid.org/0000-0002-1300-1905'}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'L Fehrenbacher', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I2800389475', 'https://openalex.org/I2800124591', 'https://openalex.org/I2802835388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070158409', 'display_name': 'Rinat Yerushalmi', 'orcid': 'https://orcid.org/0000-0001-6221-2859'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'R Yerushalmi', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5019071326', 'display_name': 'LA Mina', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'LA Mina', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I2800389475', 'https://openalex.org/I2800124591', 'https://openalex.org/I2802835388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044744499', 'display_name': 'Sara López‐Tarruella', 'orcid': 'https://orcid.org/0000-0002-2606-9538'}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'M Martin', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052648400', 'display_name': 'Henri Roché', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'H Roché', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I2800389475', 'https://openalex.org/I2800124591', 'https://openalex.org/I2802835388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083342236', 'display_name': 'Y-H Im', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'Y-H Im', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086049069', 'display_name': 'RGW Quek', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'RGW Quek', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011964835', 'display_name': 'IC Tudor', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'IC Tudor', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048581112', 'display_name': 'A. Hannah', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'AL Hannah', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I2800389475', 'https://openalex.org/I2800124591', 'https://openalex.org/I2802835388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002412211', 'display_name': 'W. Eiermann', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}, {'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'W Eiermann', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I2800124591', 'https://openalex.org/I2802835388', 'https://openalex.org/I4210167126', 'https://openalex.org/I2800389475']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5024350975', 'display_name': 'JL Blum', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210167126', 'display_name': 'UCSF Helen Diller Family Comprehensive Cancer Center', 'ror': 'https://ror.org/05yndxy10', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I180670191', 'https://openalex.org/I4210110664', 'https://openalex.org/I4210167126']}, {'id': 'https://openalex.org/I2800389475', 'display_name': 'Rabin Medical Center', 'ror': 'https://ror.org/01vjtf564', 'country_code': 'IL', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2800389475', 'https://openalex.org/I64767286']}, {'id': 'https://openalex.org/I2800124591', 'display_name': 'Texas Oncology', 'ror': 'https://ror.org/02ketev28', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I2800124591']}, {'id': 'https://openalex.org/I2802835388', 'display_name': 'Seoul National University Hospital', 'ror': 'https://ror.org/01z4nnt86', 'country_code': 'KR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2802835388']}], 'countries': ['IL', 'KR', 'US'], 'is_corresponding': False, 'raw_author_name': 'JL Blum', 'raw_affiliation_strings': ['MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX'], 'affiliations': [{'raw_affiliation_string': 'MD Anderson Cancer Center, Houston, TX; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; TU Muenchen III, Munich, Germany; University of California, Los Angeles, Los Angeles, CA; Institut Paoli-Calmettes, Marseille, France; Seoul National University Hospital, Seoul, Republic of Korea; Kaiser Permanente, Northern California, Velljo, CA; Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel; Banner Health, Phoenix, AZ; Instituto de Investigaçion Sanitaria Gregorio Maranon, Ciberonc, Universidad Complutense, Madrid, Spain; Institut Universitaire du Cancer Toulouse, Toulouse, France; Samsung Medical Center, Seoul, Republic of Korea; Pfizer, Inc., San Francisco, CA; Interdisziplinäres Onkologisches Zentrum Muenchen, Muenchen, Germany; Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Dallas, TX', 'institution_ids': ['https://openalex.org/I4210167126', 'https://openalex.org/I2800389475', 'https://openalex.org/I2800124591', 'https://openalex.org/I2802835388']}]}], 'countries_distinct_count': 3, 'institutions_distinct_count': 4, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.012, 'has_fulltext': False, 'cited_by_count': 49, 'citation_normalized_percentile': {'value': 0.861407, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '78', 'issue': '4_Supplement', 'first_page': 'GS6', 'last_page': '07'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'Poly(ADP-ribose) Polymerase Inhibition in Cancer Therapy', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10769', 'display_name': 'Genetic Research on BRCA Mutations and Cancer Risk', 'score': 0.9859, 'subfield': {'id': 'https://openalex.org/subfields/1311', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'Molecular Mechanisms of DNA Damage Response', 'score': 0.9479, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/eribulin', 'display_name': 'Eribulin', 'score': 0.8374101}, {'id': 'https://openalex.org/keywords/brca-mutation', 'display_name': 'BRCA mutation', 'score': 0.6931207}, {'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.68358576}, {'id': 'https://openalex.org/keywords/parp-inhibitors', 'display_name': 'PARP Inhibitors', 'score': 0.555003}, {'id': 'https://openalex.org/keywords/vinorelbine', 'display_name': 'Vinorelbine', 'score': 0.5458047}, {'id': 'https://openalex.org/keywords/breast-cancer', 'display_name': 'Breast Cancer', 'score': 0.500636}], 'concepts': [{'id': 'https://openalex.org/C2776387010', 'wikidata': 'https://www.wikidata.org/wiki/Q408717', 'display_name': 'Eribulin', 'level': 5, 'score': 0.8374101}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7914224}, {'id': 'https://openalex.org/C2780194787', 'wikidata': 'https://www.wikidata.org/wiki/Q4836333', 'display_name': 'BRCA mutation', 'level': 4, 'score': 0.6931207}, {'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.68358576}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6801863}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.56691813}, {'id': 'https://openalex.org/C2780350996', 'wikidata': 'https://www.wikidata.org/wiki/Q420532', 'display_name': 'Vinorelbine', 'level': 4, 'score': 0.5458047}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.5435022}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.48365676}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.4442702}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.2593364}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.09951505}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.07284573}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs17-gs6-07', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.87, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4206337895', 'https://openalex.org/W3179510584', 'https://openalex.org/W3129192144', 'https://openalex.org/W2887673034', 'https://openalex.org/W2794023096', 'https://openalex.org/W2793805641', 'https://openalex.org/W2765549059', 'https://openalex.org/W2677204097', 'https://openalex.org/W2019621848', 'https://openalex.org/W150977489'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Talazoparib': [2], '(TALA)': [3], 'is': [4, 37], 'a': [5, 75, 217, 306, 337, 449, 464, 548], 'highly': [6], 'potent,': [7], 'dual-mechanism': [8], 'PARP': [9, 14, 19, 534], 'inhibitor': [10], 'that': [11], 'inhibits': [12], 'the': [13, 46, 341, 556], 'enzyme': [15], 'and': [16, 28, 48, 74, 101, 107, 129, 142, 151, 170, 193, 211, 327, 397, 482, 547], 'effectively': [17], 'traps': [18], 'on': [20], 'single-stranded': [21], 'DNA': [22, 25], 'breaks,': [23], 'preventing': [24], 'damage': [26], 'repair': [27], 'causing': [29], 'cell': [30], 'death': [31, 431], 'in': [32, 67, 314, 340, 345, 369, 383, 412, 424, 430, 433, 444, 467, 471, 541], 'BRCA1/2-mutated': [33], 'cells.': [34], 'Methods:': [35], 'EMBRACA': [36], 'an': [38, 532], 'open-label,': [39], 'randomized,': [40], '2-arm,': [41], 'phase': [42, 527], '3': [43, 123, 528], 'trial': [44, 529], 'comparing': [45, 530], 'efficacy': [47, 457], 'safety': [49], 'of': [50, 59, 148, 207, 221, 539, 555], 'TALA': [51, 192, 215, 351, 371, 387, 438, 473], '(1': [52, 197], 'mg/day)': [53], 'with': [54, 69, 319, 390, 418, 448, 461, 463, 478, 486, 543], 'standard': [55], 'single-agent': [56], "physician's": [57, 537], 'choice': [58, 538], 'therapy': [60, 540], '(PCT)': [61], '(capecitabine,': [62], 'eribulin,': [63], 'gemcitabine,': [64], 'or': [65, 118], 'vinorelbine)': [66], 'patients': [68, 157, 201, 447, 542], 'advanced': [70, 544], 'breast': [71, 545], 'cancer': [72, 546], '(aBC)': [73], 'germline': [76, 549], 'BRCA1/2': [77], 'mutation': [78, 551], '(gBRCAmut).': [79], 'The': [80], 'primary': [81], 'objective': [82], 'was': [83, 136, 209, 312, 336, 388, 474], 'PFS': [84, 225, 441], 'assessed': [85], 'by': [86, 144, 233, 261, 276, 289, 442], 'blinded': [87], 'independent': [88], 'central': [89], 'review': [90], '(BICR).': [91], 'Secondary': [92], 'objectives:': [93, 104], 'OS,': [94], 'ORR,': [95], 'CBR': [96], 'at': [97], '24': [98], 'weeks': [99], '(CBR24),': [100], 'safety.': [102], 'Exploratory': [103], 'patient-reported': [105], 'QoL': [106], 'DOR.': [108], 'Eligibility': [109], 'criteria:': [110], 'age': [111, 161], '≥': [112], '18': [113, 199], 'years;': [114, 163], 'HER2-negative': [115, 445], 'aBC;': [116, 128, 181], 'deleterious': [117, 120], 'suspected': [119], 'gBRCAmut;': [121], '≤': [122, 132], 'prior': [124, 149, 183], 'cytotoxic': [125], 'regimens': [126], 'for': [127, 180, 350], 'ECOG': [130, 174], 'PS': [131, 175], '2.': [133], 'Prior': [134], 'platinum': [135], 'allowed.': [137], 'Patients': [138], 'were': [139, 158, 189, 202, 381, 410], 'randomized': [140, 159, 307], '2:1': [141], 'stratified': [143], 'receptor': [145], 'status,': [146], 'extent': [147], 'therapy,': [150], 'CNS': [152, 186, 328], 'metastases': [153], '(NCT01945775).': [154], 'Results:': [155], '431': [156], '(median': [160], '46': [162], '54%': [164], 'hormone-receptor': [165], '[HR]+': [166], 'BC;': [167], '45%': [168], 'BRCA1+': [169], '55%': [171, 173, 370], 'BRCA2+;': [172], '=': [176, 240, 244, 254, 258, 268, 272, 282, 286, 296, 300], '0;': [177], '38%': [178], 'chemo-naïve': [179], '18%': [182], 'platinum;': [184], '15%': [185], 'metastases);': [187], '287': [188], 'assigned': [190], 'to': [191, 195, 343, 452, 469, 536], '144': [194], 'PCT': [196, 200, 353, 374], 'TALA,': [198, 462], 'not': [203], 'treated).': [204], 'Median': [205], 'duration': [206], 'exposure': [208], '6.1': [210], '3.9': [212], 'months,': [213], 'respectively;': [214], 'had': [216], 'relative': [218], 'dose': [219], 'intensity': [220], '87%.': [222], 'At': [223], '62%': [224], 'data': [226], 'maturity:': [227], 'TALAPCTHazard': [228], 'Ratio/Odds': [229], 'Ratio': [230], '(P': [231], 'value)PFS': [232], 'BICR,': [234], 'mo': [235, 249, 278], '(95%': [236, 250, 264, 292], 'CI)8.6': [237], '(7.2-9.3);': [238], 'n': [239, 243, 253, 257, 267, 271, 281, 285, 295, 299], '2875.6': [241], '(4.2-6.7);': [242], '1440.542': [245], '(&lt;': [246, 274], '0.0001)OS': [247], '[interim],': [248], 'CI)22.3': [251], '(18.1-26.2);': [252], '28719.5': [255], '(16.3-22.4);': [256], '1440.761': [259], '(0.105)ORR': [260], 'INV,': [262, 277, 290, 303], '%': [263, 291], 'CI)62.6%': [265], '(55.8-69.0);': [266], '21927.2%': [269], '(19.3-36.3);': [270], '1144.99': [273], '0.0001)DOR': [275], '(IQR)5.4': [279], '(2.8-11.2);': [280], '1373.1': [283], '(2.4-6.7);': [284], '310.431': [287], '(0.0005)*CBR24': [288], 'CI)68.6%': [293], '(62.9-74.0);': [294], '28736.1%': [297], '(28.3-44.5);': [298], '1444.28': [301], '(≤0.0001)': [302], 'investigator.': [304], '*Not': [305], 'subset.': [308], 'Improved': [309], 'clinical': [310], 'benefit': [311, 460], 'seen': [313, 382], 'all': [315, 454], 'subsets': [316], 'including': [317], 'those': [318], 'HR+': [320], 'BC': [321], '(HR': [322, 330, 354], '0.47;': [323], '95%': [324, 332, 356], 'CI': [325, 333, 357], '0.32-0.71)': [326], 'metastasis': [329], '0.32;': [331], '0.15-0.88).': [334], 'There': [335], 'significant': [338, 465], 'delay': [339, 466], 'time': [342, 468], 'deterioration': [344, 470], 'global': [346], 'health': [347], 'status': [348], '(GHS)/QoL': [349], 'vs': [352, 395, 402], '0.38;': [355], '0.26-0.55;': [358], 'P': [359], '&lt;': [360], '0.0001].': [361], 'Grade': [362, 377, 406], '3-4': [363, 378, 407], 'hematologic': [364], 'adverse': [365], 'events': [366], '(AEs)': [367], 'occurred': [368, 423, 432], '(mainly': [372, 375], 'anemia)/39%': [373], 'neutropenia).': [376], 'non-hematologic': [379, 480], 'AEs': [380, 409, 416, 484], '32%': [384], 'TALA/38%': [385], 'PCT;': [386, 453], 'associated': [389, 417, 485], 'fewer': [391], 'gastrointestinal': [392], 'disorders': [393, 400], '(5.6%': [394], '11.9%)': [396], 'skin/subcutaneous': [398], 'tissue': [399], '(0.7%': [401], '5.6%)': [403], 'than': [404], 'PCT.': [405, 415, 427], 'serious': [408], 'observed': [411], '26%': [413], 'TALA/25%': [414], 'permanent': [419], 'study': [420], 'drug': [421], 'discontinuation': [422], '8%': [425], 'TALA/10%': [426], 'AE': [428], 'resulting': [429], '2.1%': [434], 'TALA/3.2%': [435], 'PCT.Conclusions:': [436], 'Single-agent': [437], 'significantly': [439], 'prolonged': [440], 'BICR': [443], 'aBC': [446], 'gBRCAmut': [450], 'compared': [451], 'key': [455], 'secondary': [456], 'endpoints': [458], 'demonstrated': [459], 'GHS/QoL.': [472], 'generally': [475], 'well': [476], 'tolerated': [477], 'minimal': [479], 'toxicity': [481], 'few': [483], 'treatment': [487], 'discontinuations.': [488], 'Citation': [489], 'Format:': [490], 'Litton': [491], 'J,': [492, 496], 'Rugo': [493], 'HS,': [494], 'Ettl': [495], 'Hurvitz': [497], 'S,': [498], 'Gonçalves': [499], 'A,': [500], 'Lee': [501], 'K-H,': [502], 'Fehrenbacher': [503], 'L,': [504], 'Yerushalmi': [505], 'R,': [506], 'Mina': [507], 'LA,': [508], 'Martin': [509], 'M,': [510], 'Roché': [511], 'H,': [512], 'Im': [513], 'Y-H,': [514], 'Quek': [515], 'RGW,': [516], 'Tudor': [517], 'IC,': [518], 'Hannah': [519], 'AL,': [520], 'Eiermann': [521], 'W,': [522], 'Blum': [523], 'JL.': [524], 'EMBRACA:': [525], 'A': [526], 'talazoparib,': [531], 'oral': [533], 'inhibitor,': [535], 'BRCA': [550], '[abstract].': [552], 'In:': [553], 'Proceedings': [554], '2017': [557, 563], 'San': [558, 566], 'Antonio': [559], 'Breast': [560], 'Cancer': [561, 572], 'Symposium;': [562], 'Dec': [564], '5-9;': [565], 'Antonio,': [567], 'TX.': [568], 'Philadelphia': [569], '(PA):': [570], 'AACR;': [571], 'Res': [573], '2018;78(4': [574], 'Suppl):Abstract': [575], 'nr': [576], 'GS6-07.': [577]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2794023096', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 11}, {'year': 2018, 'cited_by_count': 27}], 'updated_date': '2024-09-11T21:52:03.090462', 'created_date': '2018-03-29'}